1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow CRC: new trials by email Literature Review of CRC trials Research Report on CRC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer 5-Fluorouracil, Leucovorin, Oxaliplatin - CRC | Phase 3 | Unknown | Hellenic Oncology Research Group | 2000 | 2010-10-01 | 2017-08-09 |
Colorectal Neoplasms (1) · Neoplasms (1)
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Capecitabine (1) · Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1)
Hellenic Oncology Research Group (1)
Greece (1)
John Souglakos, MD (1) · Vassilis Georgoulias, MD (1)